The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of exogenous female hormone use (EHU) on breast cancer (BC) recurrence as assessed by the 21-gene assay (Oncotype DX).
Wendy M. Ledesma
No relevant relationships to disclose
Adedayo A. Onitilo
No relevant relationships to disclose
Chong Zhang
No relevant relationships to disclose
KyungMann Kim
No relevant relationships to disclose
Molly Andreason
No relevant relationships to disclose
John A. Charlson
No relevant relationships to disclose
Kimberly Ridolfi
No relevant relationships to disclose
Jessica Marie Engel
No relevant relationships to disclose
Kari Braun Wisinski
No relevant relationships to disclose
Robert Millholland
No relevant relationships to disclose
James T Dean
No relevant relationships to disclose
Amye Tevaarwerk
No relevant relationships to disclose